Related references
Note: Only part of the references are listed.In Vivo Pharmacodynamic Activity of Tomopenem (formerly CS-023) against Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus in a Murine Thigh Infection Model
Kiyoshi Sugihara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
In vitro postantibiotic effects of tomopenem (CS-023) against Staphylococcus aureus and Pseudomonas aeruginosa
Takanori Tomozawa et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Lack of age and gender effects on single-dose pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem
Navita L. Mallalieu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Prospects for the next anti-Pseudomonas drug
Malcolm G. P. Page et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Effect of impaired renal function on the pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenem
Navita L. Mallalieu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
In vivo pharmacodynamic profiling of doripenem against Pseudomonas aeruginosa by simulating human exposures
Aryun Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model
Yoshitomo Morinaga et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Carbapenems: a potent class of antibiotics
David P. Nicolau
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Bactericidal activities of meropenem and ertapenem against extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model
C. Andrew DeRyke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Is all free time above the minimum inhibitory concentration the same:: implications for β-lactam in vivo modelling
C. Andrew DeRyke et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Comparative review of the carbapenems
George G. Zhanel et al.
DRUGS (2007)
Pharmacokinetics of CS-023 (RO4908463), a novel parenteral carbapenem, in healthy male Caucasian volunteers
Takahiro Shibayama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem
T Koga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Defining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient
CA DeRyke et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Therapeutic efficacy of J-111,225, a novel trans-3,5-disubstituted pyrrolidinylthio-1 beta-methylcarbapenem, against experimental murine systemic infections
K Shibata et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Share Paper
